The March Rheuminations column, “Twenty Questions, Part 1” inspired many letters from TR readers. Here are just a few of those responses.
ACR REF Launches ‘Within Our Reach’
The ACR Research and Education Foundation (REF) has launched “Within Our Reach,” a national, multiyear, $30-million fundraising campaign aimed at accelerating innovative research on rheumatoid arthritis. RA—long considered one of the most disabling types of arthritis—has been a primary focus of rheumatologic research. Recent advances in the basic management of RA include targeted treatments and improvements in treating other types of inflammatory arthritis. Unfortunately, we still do not know the cause of RA or have a cure.
Science from our Sisters
Recommended reading from A&R and AC&R
Reading Rhuem
Handpicked Reviews of Contemporary Literature
Science from our Sisters
Recommended reading from A&R and AC&R
Reading Rheum
Handpicked Reviews of Contemporary Literature
Consumers Add Perspective to Arthritis Research
It has been my distinct pleasure to work with consumer collaborators—people living with arthritis—on research projects, advisory boards, and review panels, in consensus meetings to establish research agendas, and as co-educators in health professional programs. Those I work with have chosen the term “consumer collaborator” to reflect their contribution to and eventual use of our partnerships, although others might call them patients or clients.
November Coding Scenario
Think you know all there is to know about coding? Here’s a chance to find out.
A Heart In Danger
Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis
- « Previous Page
- 1
- …
- 43
- 44
- 45